Showing results (1281-1290 of 1,547) with videos related to

Sort By:
Pageof 155
Cancer Discovery|May 25, 2016
Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid TumorsAmita Patnaik, Lee S Rosen, Sara M Tolaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma PatientsEudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.
Neuro-Oncology|November 22, 2024
European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selectionFelix Sahm, Luca Bertero, Sebastian Brandner, et al.
Neuro-Oncology|June 9, 2026
BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directionsKarisa C Schreck, Macarena I de la Fuente, Mary Jane Lim Fat, et al.
Nature Communications|March 2, 2025
Multimodal histopathologic models stratify hormone receptor-positive early breast cancerKevin M Boehm, Omar S M El Nahhas, Antonio Marra, et al.
The Lancet. Oncology|November 28, 2021
Dabrafenib plus trametinib in patients with BRAF<sup>V600E</sup>-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trialPatrick Y Wen, Alexander Stein, Martin van den Bent, et al.
Neuro-Oncology|June 10, 2020
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomasJerrold L Boxerman, Chad C Quarles, Leland S Hu, et al.
Science Signaling|December 17, 2009
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapyDeliang Guo, Robert M Prins, Julie Dang, et al.
Neuro-Oncology|August 8, 2015
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trialsBenjamin M Ellingson, Martin Bendszus, Jerrold Boxerman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 4, 2020
Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarityFresia Pareja, Edaise M da Silva, Denise Frosina, et al.
Pageof 155